Apogem Capital LLC Alnylam Pharmaceuticals, Inc. Transaction History

Apogem Capital LLC

  • $303 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$120.42 - $169.29 $200,980 - $282,545
-1,669 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$127.18 - $173.91 $92,714 - $126,780
-729 Reduced 30.4%
1,669 $273,000
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $382,624 - $501,877
2,398 New
2,398 $407,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Apogem Capital LLC Portfolio

Follow Apogem Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apogem Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email